Delineating Physiologic Mechanisms of Swallowing impairment and Decline in ALS
描绘吞咽障碍和 ALS 衰退的生理机制
基本信息
- 批准号:9891114
- 负责人:
- 金额:$ 35.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAmyotrophic Lateral SclerosisAnatomyAspirate substanceAspiration PneumoniaBiological MarkersCaregiver BurdenClinicalClinical Assessment ToolClinical ManagementClinical MarkersClinical ResearchClinical TrialsCoughingDataDeglutitionDeglutition DisordersDehydrationDenervationDependenceDetectionDeteriorationDevelopmentDiseaseEarly DiagnosisEarly identificationEnsureEnteral FeedingEsophagusEvaluationFoodFoundationsFunctional disorderFutureGoalsGoldHealthHealth Care CostsImpairmentIndividualIntakeInterventionIsometric ExerciseKnowledgeLarynxLeadLungMalnutritionMediatingModelingMonitorMotorMuscle WeaknessMyographyNeurodegenerative DisordersNutritionalOralOral cavityOutcomeOutcomes ResearchPatientsPatternPhenotypePhysiologicalPopulationPractice GuidelinesProceduresPublic HealthQuality of lifeReceiver Operating CharacteristicsRecommendationReflex actionResearch DesignRiskSafetySensorySpinalStomachStructureTechniquesTestingTherapeuticTimeTime ManagementTongueVestibuleWorkbaseclinical careclinical practiceclinical predictorsconstrictiondesigndiagnosis evaluationdisease diagnosiselectric impedanceevidence basefunctional declineimprovedindexinginsightlongitudinal datasetmortalitymortality riskmotor impairmentnovelnutritionpatient populationpredictive modelingpredictive toolspressurepulmonary functionresponsetooltreatment effecttreatment strategy
项目摘要
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease causing progressive muscle
weakness and impairments in swallowing (dysphagia). Dysphagia leads to malnutrition, dehydration, tracheal
aspiration and pneumonia that contribute to 26% of ALS mortality. The current proposal is strongly motivated
by fundamental knowledge gaps that have contributed to sub-optimal clinical care of individuals with ALS
and a lack of formal practice guidelines in the management of progressive swallowing impairment in ALS.
The overarching goal of this work is to improve clinical practice by 1) increasing our understanding of
governing mechanisms and progression of dysphagia in ALS and 2) identification of sensitive biomarkers of
swallowing dysfunction to build a clinical dysphagia risk index tool. We will perform serial instrumental
swallowing evaluations in 100 individuals with ALS (50 bulbar-onset, 50 spinal-onset) from disease diagnosis
to feeding-tube dependence and provide critical longitudinal data to help establish the first time-course model
of ALS swallowing decline. Such a model is needed to guide best practice recommendations, optimal timing of
interventions, for planning and design of future clinical trials, and for interpretation of experimental treatment
effects. We will also test the discriminant ability and clinical utility of a set of promising clinical markers of
swallowing decline that are pragmatically designed for easy dissemination into ALS clinical settings. Our long-
term goal is to improve clinical care of swallowing disorders in ALS. The proposed study will deliver new
insights into the pathophysiologic mechanisms of unsafe and inefficient swallowing in ALS to drive the
development of future intervention strategies and lead to earlier and more accurate identification of
swallowing impairment. Earlier identification and better treatment strategies for swallowing dysfunction in ALS
will lead to improvements in oral intake, nutrition, pulmonary health and quality of life and ultimately reduce
aspiration pneumonia associated mortality in this challenging population.
肌萎缩侧索硬化症(ALS)是一种致命的神经退行性疾病,导致进行性肌肉
吞咽无力和功能障碍(吞咽困难)。吞咽困难导致营养不良、脱水、气管
吸入性疾病和肺炎占ALS死亡率的26%。目前的提议具有强烈的动机
由于基础知识差距导致ALS患者的临床护理不够理想
在渐进性肌萎缩侧索硬化症患者的进行性吞咽障碍的管理方面缺乏正式的实践指南。
这项工作的首要目标是通过以下方式改善临床实践:1)增加对
肌萎缩侧索硬化症吞咽困难的调控机制和进展及2)敏感生物标志物的鉴定
吞咽功能障碍构建临床吞咽困难危险指数工具。我们将表演连载器乐
100例ALS患者(球部和脊椎各50例)的吞咽功能评估
提供关键的纵向数据,以帮助建立第一个时程模型
肌萎缩侧索硬化症吞噬能力下降。需要这样的模型来指导最佳实践建议、最佳时机
干预措施,用于规划和设计未来的临床试验,并用于解释实验性治疗
效果。我们还将测试一组有希望的临床标志物的判别能力和临床实用价值。
吞咽下降,是务实的设计,易于传播到ALS临床环境。我们的长-
学期目标是改善ALS患者吞咽障碍的临床护理。拟议的研究将带来新的
对肌萎缩侧索硬化症患者不安全和低效吞咽的病理生理机制的见解
制定未来的干预策略,并导致更早和更准确地识别
吞咽障碍。肌萎缩侧索硬化症患者吞咽功能障碍的早期识别和更好的治疗策略
将导致口服摄入量、营养、肺部健康和生活质量的改善,并最终减少
在这一具有挑战性的人群中,吸入性肺炎与死亡率相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emily Kate Plowman其他文献
Emily Kate Plowman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emily Kate Plowman', 18)}}的其他基金
Delineating Physiologic Mechanisms of Swallowing impairment and Decline in ALS
描绘吞咽障碍和 ALS 衰退的生理机制
- 批准号:
9286256 - 财政年份:2017
- 资助金额:
$ 35.21万 - 项目类别:
Effects of Strength Training on Bulbar Function in Amyotrophic Lateral Sclerosis
力量训练对肌萎缩侧索硬化症延髓功能的影响
- 批准号:
8582789 - 财政年份:2013
- 资助金额:
$ 35.21万 - 项目类别:
Dissociating the Neural Substrates of Cranial and Limb Motor Impairment in an Ani
分离肛门中颅骨和肢体运动障碍的神经基质
- 批准号:
8231836 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
Dissociating the Neural Substrates of Cranial and Limb Motor Impairment in an Ani
分离肛门中颅骨和肢体运动障碍的神经基质
- 批准号:
8336857 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
Dissociating the Neural Substrates of Cranial and Limb Motor Impairment in an Ani
分离肛门中颅骨和肢体运动障碍的神经基质
- 批准号:
8526447 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing
建立吞咽定量电视透视测量的参考值和临床决策点
- 批准号:
10445103 - 财政年份:2010
- 资助金额:
$ 35.21万 - 项目类别:
Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing
建立吞咽定量电视透视测量的参考值和临床决策点
- 批准号:
10673194 - 财政年份:2010
- 资助金额:
$ 35.21万 - 项目类别:
Neural Substrates of Oral Motor Dysfunction in Parkinson's Disease
帕金森病口腔运动功能障碍的神经基质
- 批准号:
7912217 - 财政年份:2009
- 资助金额:
$ 35.21万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 35.21万 - 项目类别:
Fellowship